Cryoballoon pulmonary vein isolation for atrial fibrillation in obese patients: A non-inferiority analysis

Chooi, 2019, The epidemiology of obesity, Metabolism, 92, 6, 10.1016/j.metabol.2018.09.005 Powell-Wiley, 2021, Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association, Circulation, 143, e984, 10.1161/CIR.0000000000000973 Guembe, 2020, Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort, Cardiovasc. Diabetol., 19, 195, 10.1186/s12933-020-01166-6 Wang, 2019, Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week, J. Am. Coll. Cardiol., 74, 1107, 10.1016/j.jacc.2019.07.020 Hindricks, 2020, 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS), Eur. Heart. J Winkle, 2017, Impact of obesity on atrial fibrillation ablation: Patient characteristics, long-term outcomes, and complications, Heart. Rhythm, 14, 819, 10.1016/j.hrthm.2017.02.023 Wong, 2015, Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation: A Meta-Analysis of 626,603 Individuals in 51 Studies, JACC. Clin. Electrophysiol., 1, 139, 10.1016/j.jacep.2015.04.004 Tonnesen, 2023, Short- and long-term risk of atrial fibrillation recurrence after first time ablation according to body mass index: a nationwide Danish cohort study, Europace, 25, 425, 10.1093/europace/euac225 Providencia, 2019, Impact of Body Mass Index on the Outcomes of Catheter Ablation of Atrial Fibrillation: A European Observational Multicenter Study, J. Am. Heart. Assoc., 8, e012253, 10.1161/JAHA.119.012253 Glover, 2019, Impact of body mass index on the outcome of catheter ablation of atrial fibrillation, Heart, 105, 244, 10.1136/heartjnl-2018-313490 Prasitlumkum, 2022, Utilization and in-hospital complications of catheter ablation for atrial fibrillation in patients with obesity and morbid obesity, Clin. Cardiol., 45, 407, 10.1002/clc.23795 De Maat, 2018, Obesity is associated with impaired long-term success of pulmonary vein isolation: a plea for risk factor management before ablation, Open. Heart., 5, e000771, 10.1136/openhrt-2017-000771 Weinmann, 2020, Pulmonary vein isolation with the cryoballoon in obese atrial fibrillation patients - Does weight have an impact on procedural parameters and clinical outcome?, Int. J. Cardiol., 316, 137, 10.1016/j.ijcard.2020.06.001 Malaspina, 2021, Cryoablation for pulmonary veins isolation in obese patients with atrial fibrillation compared to nonobese patients, Pacing. Clin. Electrophysiol., 44, 306, 10.1111/pace.14149 Wolfes, 2022, Pulmonary Vein Isolation in Obese Compared to Non-Obese Patients: Real-Life Experience from a Large Tertiary Center, J. Cardiovasc. Dev. Dis., 9 Pathak, 2015, Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY), J. Am. Coll. Cardiol., 65, 2159, 10.1016/j.jacc.2015.03.002 Pathak, 2014, Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study, J. Am. Coll. Cardiol., 64, 2222, 10.1016/j.jacc.2014.09.028 Seyed Ahmadi, 2020, Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study, Cardiovasc. Diabetol., 19, 9, 10.1186/s12933-019-0983-1 Donnellan, 2019, Association Between Pre-Ablation Glycemic Control and Outcomes Among Patients With Diabetes Undergoing Atrial Fibrillation Ablation, JACC. Clin. Electrophysiol., 5, 897, 10.1016/j.jacep.2019.05.018 Wang, 2020, Catheter ablation of atrial fibrillation in patients with diabetes mellitus, Heart. Rhythm. O2., 1, 180, 10.1016/j.hroo.2020.04.006 Anselmino, 2015, Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis, Europace, 17, 1518, 10.1093/europace/euv214 Echouffo-Tcheugui, 2017, Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry, J. Am. Coll. Cardiol., 70, 1325, 10.1016/j.jacc.2017.07.755 Andrade, 2021, Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation, N. Engl. J. Med., 384, 305, 10.1056/NEJMoa2029980 Kirchhof, 2020, Early Rhythm-Control Therapy in Patients with Atrial Fibrillation, N. Engl. J. Med., 383, 1305, 10.1056/NEJMoa2019422 Yao, 2011, Allometric model improves scaling of left atrial size in obese population: the use of body weight containing variables is challenged, Echocardiography, 28, 253, 10.1111/j.1540-8175.2010.01337.x Jeyaprakash, 2021, A Systematic Review of Scaling Left Atrial Size: Are Alternative Indexation Methods Required for an Increasingly Obese Population?, J. Am. Soc. Echocardiogr., 34, 1067, 10.1016/j.echo.2021.05.009 E.J. Nassri Camara, F.R. do Prado Valladares, N.K. Key, et al. Indexing of Left Atrial Volume by Body Surface Area and Height in a Brazilian Population without Previous Heart Disease and with a Normal Heart on Echocardiography. Behavior in Obese and Overweight Patients. Cardiol. Cardiovasc. Med. 2023;7(1):25-31. Kuck, 2016, Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial, Eur. Heart. J., 37, 2858, 10.1093/eurheartj/ehw285 Wazni, 2021, Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation, N. Engl. J. Med., 384, 316, 10.1056/NEJMoa2029554 Boehmer, 2022, Process optimization for atrial fibrillation ablation, Europace, 24, 1763, 10.1093/europace/euac048 Asad, 2018, Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis, J. Cardiovasc. Electrophysiol., 29, 725, 10.1111/jce.13458 Nystrom, 2015, Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study, PLoS. One, 10, e0127111, 10.1371/journal.pone.0127111 Tsang, 2008, Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years, Eur. Heart. J., 29, 2227, 10.1093/eurheartj/ehn324 Gawalko, 2022, Adiposity-associated atrial fibrillation: molecular determinants, mechanisms and clinical significance, Cardiovasc. Res Magnani, 2013, Obesity begets atrial fibrillation: a contemporary summary, Circulation, 128, 401, 10.1161/CIRCULATIONAHA.113.001840 Vyas, 2019, Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities, Arrhythm. Electrophysiol. Rev., 8, 28, 10.15420/aer.2018.76.2 Wong, 2016, Associations of Epicardial, Abdominal, and Overall Adiposity With Atrial Fibrillation, Circ. Arrhythm. Electrophysiol., 9, 10.1161/CIRCEP.116.004378 Mahajan, 2018, Electroanatomical Remodeling of the Atria in Obesity: Impact of Adjacent Epicardial Fat, JACC. Clin. Electrophysiol., 4, 1529, 10.1016/j.jacep.2018.08.014 Chen, 2012, Epicardial adipose tissue and neural mechanisms of atrial fibrillation, Circ. Arrhythm. Electrophysiol., 5, 618, 10.1161/CIRCEP.112.974956 Creta, 2020, Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study), Am. J. Cardiol., 125, 901, 10.1016/j.amjcard.2019.12.037 Krijthe, 2013, Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060, Eur. Heart. J., 34, 2746, 10.1093/eurheartj/eht280 Boehmer, 2022, Persistent Atrial Fibrillation in Elderly Patients: Limited Efficacy of Pulmonary Vein Isolation, J. Clin. Med., 11, 10.3390/jcm11206070 Gessler, 2021, Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial, Europace, 23, 1548, 10.1093/europace/euab122